Evofem Biosciences, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EVFM research report →
Companywww.evofem.com
Evofem Biosciences, Inc. , a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy.
- CEO
- Saundra Pelletier
- IPO
- 2014
- Employees
- 32
- HQ
- San Diego, CA, US
Price Chart
Valuation
- Market Cap
- $808.43K
- P/E
- -0.13
- P/S
- 0.04
- P/B
- -0.01
- EV/EBITDA
- -22.16
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 74.13%
- Op Margin
- -17.08%
- Net Margin
- -29.90%
- ROE
- 8.58%
- ROIC
- 78.23%
Growth & Income
- Revenue
- $20.18M · 4.23%
- Net Income
- $391.00K · 104.41%
- EPS
- $0.00 · 102.39%
- Op Income
- $1.44M
- FCF YoY
- 48.78%
Performance & Tape
- 52W High
- $0.02
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- -1.31
- Avg Volume
- 188.41K
Get TickerSpark's AI analysis on EVFM
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 12, 24 | Zhang Yan | sell | 104 |
| Dec 21, 23 | Kamdar Kim P. | sell | 10 |
| Dec 31, 22 | File Justin J. | other | 0 |
| Dec 31, 22 | PELLETIER SAUNDRA L | sell | 50,000 |
| Apr 13, 23 | Zhang Yan | other | 0 |
| Aug 2, 22 | Yip Jenny C. | other | 0 |
| May 31, 22 | Atkinson Katherine Cocca | other | 0 |
| May 31, 22 | Atkinson Katherine Cocca | other | 6,667 |
| May 31, 22 | Atkinson Katherine Cocca | other | 4,000 |
| May 27, 22 | PELLETIER SAUNDRA L | buy | 141,000 |
Our EVFM Coverage
We haven't published any research on EVFM yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate EVFM Report →